News
Eli Lilly to Invest over $6bn on the New Huntsville Facility
With an intent to make the incurable curable, Huntsville may as well become the right place of biopharma production in the next decade.
Eli Lilly, the pharmaceutical giant, announced plans on December 9, 2025, to invest over $6bn on the...
BioPharma
Thermo Fisher to Expand Bioprocess Design Centers in Asia
Thermo Fisher Scientific has gone on to announce quite a major expansion of its Bioprocess Design Centers in Asia, hence deepening its investment within the rapidly advancing biopharmaceutical sector of the region. The company is now starting a new...
BioPharma
Bora – Corealis Collaborate for Oral Solid Dose Development
Bora Pharmaceuticals Co. Ltd., which is a global leader when it comes to pharmaceutical manufacturing, along with a leading early-phase Contract Development Manufacturing Organization – CDMO, Corealis Pharma Inc., have gone on to enter into a strategic alliance so...
Clinical Trials
Eli Lilly & IU Join Hands to Expand Clinical Trials Access
A new agreement as per which Eli Lilly and Company is going to offer almost $40 million to Indiana University - IU has come to the fore. As Eli Lilly & IU join hands to expand access to clinical...
BioPharma
IQVIA Agentic AI Platform Builds New Capabilities with AWS
IQVIA, known across the life sciences industry for its clinical research operations, commercial analytics, and health-data expertise, has entered a strategic collaboration with Amazon Web Services (AWS), naming AWS as its Preferred Agentic Cloud Provider. Announced during AWS re:Invent,...
News
Industrial Boiler Water Treatment: Best Practices For Modern Plant Operations
Industrial boilers sit at the center of many plant operations, from heating and power to a wide range of industrial process needs. Because they run for long stretches, they depend on steady care. Water treatment is one of the...
BioPharma
Regeneron Looks to Infusing More Funds into Gene Editing
Regeneron Pharmaceuticals is going ahead and investing more funds into gene editing, as it has announced a collaboration with Tessera Therapeutics in December 2025, so as to create an experimental program pertaining to rare liver and lung disease.
At the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.